HCP5 and central nervous system cancer: In the basal subtype of breast cancer, HCP5 was bound to miRNA-155, affecting cell proliferation and aggressiveness of tumor [140], whereas in glioma, malignancy was shown to be regulated by an HCP5-miRNA-139-RUNX1 feedback loop.